摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

methyl 1-(4-hydroxy-3-methoxyphenyl)-1,2,3,4-tetrahydro-β-carboline-3-carboxylate | 528524-55-2

中文名称
——
中文别名
——
英文名称
methyl 1-(4-hydroxy-3-methoxyphenyl)-1,2,3,4-tetrahydro-β-carboline-3-carboxylate
英文别名
cis-1-(3-methoxy-4-hydroxyphenyl)-3-carbomethoxy-1,2,3,4,tetrahydro-β-carboline;Methyl 1,2,3,4-Tetrahydro-l-(4-Hydroxy-3-Methoxyphenyl)-9H-Pyrido(3,4-b)Indole-3-Carboxylate;methyl 1-(4-hydroxy-3-methoxyphenyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate
methyl 1-(4-hydroxy-3-methoxyphenyl)-1,2,3,4-tetrahydro-β-carboline-3-carboxylate化学式
CAS
528524-55-2
化学式
C20H20N2O4
mdl
——
分子量
352.39
InChiKey
BGCTZYDFAWJFDE-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.8
  • 重原子数:
    26
  • 可旋转键数:
    4
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.25
  • 拓扑面积:
    83.6
  • 氢给体数:
    3
  • 氢受体数:
    5

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    L-色氨酸甲酯香草醛 以gave the title compound as a cream solid m.p.: 195° C.的产率得到methyl 1-(4-hydroxy-3-methoxyphenyl)-1,2,3,4-tetrahydro-β-carboline-3-carboxylate
    参考文献:
    名称:
    Tetracyclic derivatives, process of preparation and use
    摘要:
    化合物公式(I) ##STR1## 以及其盐和溶剂化物,其中:R.sup.0代表氢、卤素或C.sub.1-6烷基;R.sup.1代表氢、C.sub.1-6烷基、C.sub.2-6烯基、C.sub.2-6炔基、卤代C.sub.1-6烷基、C.sub.3-8环烷基、C.sub.3-8环烷基C.sub.1-3烷基、芳基C.sub.1-3烷基或杂环芳基C.sub.1-3烷基;R.sup.2代表一个可选的取代的单环芳香环,选择自苯、噻吩、呋喃和吡啶或一个可选的取代的双环环 ##STR2## 通过苯环碳原子之一连接到分子的其余部分,其中融合环A是一个5-或6-成员环,可以是饱和的或部分或完全不饱和的,并包括碳原子和可选的一个或两个来自氧、硫和氮的杂原子;R.sup.3代表氢或C.sub.1-3烷基,或R.sup.1和R.sup.3一起代表一个3-或4-成员的烷基或烯基链。公式(I)化合物是环鸟苷酸3',5'-单磷酸特异性磷酸二酯酶(CGMP特异性PDE)的有效选择性抑制剂,在许多治疗领域中具有有益的抑制作用,包括心血管疾病的治疗。
    公开号:
    US06025494A1
点击查看最新优质反应信息

文献信息

  • Cytotoxic and Insecticidal Activities of Derivatives of Harmine, a Natural Insecticidal Component Isolated from Peganum harmala
    作者:Yong Zeng、Yaomou Zhang、Qunfang Weng、Meiying Hu、Guohua Zhong
    DOI:10.3390/molecules15117775
    日期:——
    develop novel β-carbolines endowed with better insecticidal activity, a simple high-yielding method for the synthesis of harmine compounds starting from L-tryptophan has been developed and a series of 1,3-substituted β-carboline derivatives have been synthesized and evaluated for their cytotoxicity against insect cultured Sf9 cell line in vitro and insecticidal activities against 4th instar larvae of mosquitos
    在不断努力开发具有更好杀虫活性的新型 β-咔啉的过程中,开发了一种以 L-色氨酸为原料合成有害化合物的简单高产方法,并开发了一系列 1,3-取代的 β-咔啉衍生物合成并评估了它们对昆虫培养的 Sf9 细胞系的体外细胞毒性和对蚊子 4 龄幼虫库蚊和芥子蚜虫 Lipaphis erysimi 的杀虫活性。结果表明,1-苯基-1,2,3,4-四氢-β-咔啉-3-羧酸(化合物2)和1-苯基-β-咔啉-3-羧酸甲酯(化合物13)代表最佳潜在的化合物,在 50-200 mg/L 的浓度下处理 24 小时后,Sf9 细胞的抑制率分别为 71.55% 和 60.21%。化合物2和13对蚊子4龄幼虫也表现出较强的杀虫活性,LC(50)值为20.82 mg/L和23.98 mg/L,LC(90)值为88.29 mg/L和295.13 mg/L , 分别。此外,化合物2和13对芥菜蚜虫的LC(50)值为53.16
  • Tetracyclic derivatives, process of preparation and use
    申请人:ICOS Corporation
    公开号:US20020119976A1
    公开(公告)日:2002-08-29
    A compound of formula (I) 1 and salts and solvates thereof, in which: R o represents hydrogen, halogen or C 1-6 alkyl; R 1 represents hydrogen, C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, halo C 1-6 alkyl, C 3-8 cycloalkyl, C 3-8 cycloalkyl C 1-3 alkyl, arylC 1-3 alkyl or heteroaryl C 1-3 alkyl; R 2 represents an optionally substituted monocyclic aromatic ring selected from benzene, thiophene, furan and pyridine or an optionally substituted bicyclic ring 2 attached to the rest of the molecule via one of the benzene ring carbon atoms and wherein the fused ring A is a 5- or 6-membered ring which may be saturated or partially or fully unsaturated and comprises carbon atoms and optionally one or two heteroatoms selected from oxygen, sulphur and nitrogen; and R 3 represents hydrogen or C 1-3 alkyl, or R 1 and R 3 together represent a 3- or 4-membered alkyl or alkenyl chain. A compound of formula (I) is a potent and'selective inhibitor of cyclic guanosine 3′, 5′-monophosphate specific phosphodiesterase (CGMP specific PDE) having a utility in a variety of therapeutic areas where such inhibition is beneficial, including the treatment of cardiovascular disorders.
    式(I)1的化合物及其盐和溶剂化物,其中:R代表氢,卤素或C1-6烷基;R1代表氢,C1-6烷基,C2-6烯基,C2-6炔基,卤代C1-6烷基,C3-8环烷基,C3-8环烷基C1-3烷基,芳基C1-3烷基或杂环芳基C1-3烷基;R2代表一个可选的取代的单环芳香环,选择自苯,噻吩,呋喃和吡啶或一个可选的取代的二环2,通过苯环碳原子之一连接到分子的其余部分,其中融合的环A是一个5-或6-成员环,可以是饱和的或部分或完全不饱和的,并包括碳原子和可选的一个或两个异原子,选择自氧,硫和氮;R3代表氢或C1-3烷基,或R1和R3一起代表一个3-或4-成员烷基或烯基链。式(I)的化合物是环鸟苷3',5'-单磷酸特异性磷酸二酯酶(CGMP特异性PDE)的有效和选择性抑制剂,具有在多种治疗领域中抑制有益的功效,包括心血管疾病的治疗。
  • Method of inhibiting neoplastic cells with tetracyclic pyrido[3,4-B] indole derivatives
    申请人:——
    公开号:US20020035111A1
    公开(公告)日:2002-03-21
    A method for inhibiting neoplasia, particularly cancerous and precancerous lesions by exposing the affected cells to pyrido[3,4b]indoles.
    一种通过将受影响的细胞暴露于吡啶并[3,4b]吲哚来抑制肿瘤,特别是癌症和癌前病变的方法。
  • Tetracyclic derivatives; process of preparation and use
    申请人:ICOS Corporation
    公开号:US05859006A1
    公开(公告)日:1999-01-12
    A compound of formula (I) ##STR1## and salts and solvates thereof, in which: R.sup.0 represents hydrogen, halogen or C.sub.1-6 alkyl; R.sup.1 represents hydrogen, C.sub.1-6 alkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, haloC.sub.1-6 alkyl, C.sub.3-8 cycloalkyl, C.sub.3-8 cycloalkylC.sub.1-3 alkyl, arylC.sub.1-3 alkyl or heteroarylC.sub.1-3 alkyl; R.sup.2 represents an optionally substituted monocyclic aromatic ring selected from benzene, thiophene, furan and pyridine or an optionally substituted bicyclic ring ##STR2## attached to the rest of the molecule via one of the benzene ring carbon atoms and wherein the fused ring A is a 5- or 6-membered ring which may be saturated or partially or fully unsaturated and comprises carbon atoms and optionally one or two heteroatoms selected from oxygen, sulphur and nitrogen; and R.sup.3 represents hydrogen or C.sub.1-3 alkyl, or R.sup.1 and R.sup.3 together represent a 3- or 4-membered alkyl or alkenyl chain. A compound of formula (I) is a potent and selective inhibitor of cyclic guanosine 3', 5'-monophosphate specific phosphodiesterase (cGMP specific PDE) having a utility in a variety of therapeutic areas where such inhibition is beneficial, including the treatment of cardiovascular disorders.
    化合物的公式(I) ##STR1## 及其盐和溶剂化物,其中:R.sup.0代表氢,卤素或C.sub.1-6烷基;R.sup.1代表氢,C.sub.1-6烷基,C.sub.2-6烯基,C.sub.2-6炔基,卤代C.sub.1-6烷基,C.sub.3-8环烷基,C.sub.3-8环烷基C.sub.1-3烷基,芳基C.sub.1-3烷基或杂芳基C.sub.1-3烷基;R.sup.2代表一种可选的取代的单环芳香环,选择自苯,噻吩,呋喃和吡啶或一种可选的取代的双环环 ##STR2## 通过苯环碳原子之一连接到分子的其余部分,并且融合的环A是一个5-或6-成员环,可以是饱和的或部分或完全不饱和的,并且包括碳原子和可选的一个或两个来自氧,硫和氮的杂原子;R.sup.3代表氢或C.sub.1-3烷基,或R.sup.1和R.sup.3一起代表3-或4-成员烷基或烯基链。公式(I)的化合物是环鸟苷3',5'-单磷酸特异性磷酸二酯酶(cGMP特异性PDE)的有效选择性抑制剂,在许多治疗领域中具有益处,包括心血管疾病的治疗。
  • (6R,12aR)-2,3,6,7,12,12a-hexahydro-2-methyl-6-(3,4-methylenedioxyphenyl)-pyrazino[2',1':6,1]pyrido[3,4-b]indole-1,4-dione for the treatment of benign prostatic hypertrophy
    申请人:ICOS Corporation
    公开号:EP2036560A1
    公开(公告)日:2009-03-18
    Compound (6R,12aR)-2,3,6,7,12,12a-hexahydro-2-methyl-6-(3,4-methylenedioxyphenyl)-pyrazino [2', 1':6,1]pyrido[3,4-b]indcle-1,4-dione for the treatment of benign prostatic hypertrophy.
    用于治疗良性前列腺肥大的化合物 (6R,12aR)-2,3,6,7,12,12a-六氢-2-甲基-6-(3,4-亚甲基二氧苯基)-吡嗪并[2', 1':6,1]pyrido[3,4-b]indcle-1,4- 二酮。
查看更多